Product Program year 2025 Source: CMS Open Payments

alfapump System

Device Treatment of recurrent or refractory ascites due to liver cirrhosis

PDI 07640168020507

Open in the dashboard

General payments

$8,505

42 payments

Research payments

$285,536

8 payments

Through program year 2025, $8,505 in general payments and $285,536 in research payments were reported against alfapump System (Treatment of recurrent or refractory ascites due to liver cirrhosis).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2025 General $8,505 42
2025 Research $285,536 8

Breakdown

Who paid General payments · program year 2025
  1. Sequana Medical US Inc. $8,505 42 payments
Top recipients General payments · program year 2025
  1. Kuchikala Reddy Gastroenterology · Philadelphia, PA $3,390 40% · 2 payments
  2. Hugo Vargas Gastroenterology · Scottsdale, AZ $260 3% · 3 payments
  3. Raj Vuppalanchi Internal Medicine · Indianapolis, IN $222 3% · 1 payment
  4. Amy Johnson Hospice and Palliative Medicine · Indianapolis, IN $222 3% · 1 payment
  5. Archita Desai Gastroenterology · Indianapolis, IN $222 3% · 1 payment

The top 5 of 36 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Gastroenterology Internal Medicine $5,774 68% · 15 practitioners
  2. Vascular & Interventional Radiology Radiology $804 9% · 5 practitioners
  3. Internal Medicine $757 9% · 4 practitioners
  4. Physician Assistant $644 8% · 3 practitioners
  5. Transplant Hepatology Internal Medicine $231 3% · 5 practitioners

The top 5 of 8 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Pennsylvania $3,480 41% · 2 recipients
  2. Indiana $1,556 18% · 7 recipients
  3. Arizona $1,298 15% · 6 recipients
  4. Nevada $892 10% · 5 recipients
  5. California $703 8% · 5 recipients

The top 5 of 10 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

42 general · 8 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record